BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26850040)

  • 1. Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.
    Demark-Wahnefried W; Nix JW; Hunter GR; Rais-Bahrami S; Desmond RA; Chacko B; Morrow CD; Azrad M; Frugé AD; Tsuruta Y; Ptacek T; Tully SA; Segal R; Grizzle WE
    BMC Cancer; 2016 Feb; 16():61. PubMed ID: 26850040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
    Demark-Wahnefried W; Rais-Bahrami S; Desmond RA; Gordetsky JB; Hunter GR; Yang ES; Azrad M; Frugé AD; Tsuruta Y; Norian LA; Segal R; Grizzle WE
    Br J Cancer; 2017 Oct; 117(9):1303-1313. PubMed ID: 28881355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trial.
    Tsuruta Y; Rogers LQ; Krontiras H; Grizzle WE; Frugé AD; Oster RA; Umphrey HR; Jones LW; Azrad M; Demark-Wahnefried W
    BMJ Open; 2016 Sep; 6(9):e012320. PubMed ID: 27633639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II prospective randomized trial of weight loss prior to radical prostatectomy.
    Henning SM; Galet C; Gollapudi K; Byrd JB; Liang P; Li Z; Grogan T; Elashoff D; Magyar CE; Said J; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):212-220. PubMed ID: 29203893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum to: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.
    Demark-Wahnefried W; Nix JW; Hunter GR; Rais-Bahrami S; Desmond RA; Chacko B; Morrow CD; Azrad M; Frugé AD; Tsuruta Y; Ptacek T; Tully SA; Segal R; Grizzle WE
    BMC Cancer; 2017 Jan; 17(1):71. PubMed ID: 28114897
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.
    Demark-Wahnefried W; Rogers LQ; Gibson JT; Harada S; Frugé AD; Oster RA; Grizzle WE; Norian LA; Yang ES; Della Manna D; Jones LW; Azrad M; Krontiras H
    Int J Cancer; 2020 May; 146(10):2784-2796. PubMed ID: 31442303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial.
    Wright JL; Plymate S; D'Oria-Cameron A; Bain C; Haugk K; Xiao L; Lin DW; Stanford JL; McTiernan A
    Prostate; 2013 Sep; 73(12):1345-51. PubMed ID: 23775525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial.
    Sheill G; Brady L; Guinan E; Hayes B; Casey O; Greene J; Vlajnic T; Cahill F; Van Hemelrijck M; Peat N; Rudman S; Hussey J; Cunningham M; Grogan L; Lynch T; Manecksha RP; McCaffrey J; Mucci L; Sheils O; O'Leary J; O'Donnell DM; McDermott R; Finn S
    Trials; 2017 Oct; 18(1):456. PubMed ID: 28978344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Frugé AD; Ptacek T; Tsuruta Y; Morrow CD; Azrad M; Desmond RA; Hunter GR; Rais-Bahrami S; Demark-Wahnefried W
    J Acad Nutr Diet; 2018 Apr; 118(4):714-723.e1. PubMed ID: 27988219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
    Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
    Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy.
    Dimachkie MD; Bechtel MD; Robertson HL; Michel C; Lee EK; Sullivan DK; Chalise P; Thrasher JB; Parker WP; Godwin AK; Pathak HB; DiGiovanni J; Shivappa N; Hébert JR; Hamilton-Reeves JM
    Urol Oncol; 2021 Aug; 39(8):495.e7-495.e15. PubMed ID: 33563536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial.
    Hackshaw-McGeagh L; Lane JA; Persad R; Gillatt D; Holly JM; Koupparis A; Rowe E; Johnston L; Cloete J; Shiridzinomwa C; Abrams P; Penfold CM; Bahl A; Oxley J; Perks CM; Martin R
    Trials; 2016 Mar; 17(1):123. PubMed ID: 26948468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
    Wright JL; Schenk JM; Gulati R; Beatty SJ; VanDoren M; Lin DW; Porter MP; Morrissey C; Dash A; Gore JL; Etzioni R; Plymate SR; Neuhouser ML
    Cancer; 2024 Jun; 130(12):2108-2119. PubMed ID: 38353455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer.
    Hackshaw-McGeagh LE; Penfold C; Shingler E; Robles LA; Perks CM; Holly JMP; Rowe E; Koupparis A; Bahl A; Persad R; Shiridzinomwa C; Johnson L; Biernacka KM; Frankow A; Woodside JV; Gilchrist S; Oxley J; Abrams P; Lane JA; Martin RM
    BMJ Open; 2019 Nov; 9(11):e029480. PubMed ID: 31699723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).
    Schenk JM; Neuhouser ML; Beatty SJ; VanDoren M; Lin DW; Porter M; Gore JL; Gulati R; Plymate SR; Wright JL
    Contemp Clin Trials; 2019 Jun; 81():34-39. PubMed ID: 31002955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-help diet and physical activity intervention with dietetic support for weight management in men treated for prostate cancer: pilot study of the Prostate Cancer Weight Management (PRO-MAN) randomised controlled trial.
    Mohamad H; Ntessalen M; Craig LCA; Clark J; Fielding S; N'Dow J; Heys SD; McNeill G
    Br J Nutr; 2019 Sep; 122(5):592-600. PubMed ID: 31177994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.
    van Gemert WA; May AM; Schuit AJ; Oosterhof BY; Peeters PH; Monninkhof EM
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):799-806. PubMed ID: 26908432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study.
    Harrigan M; Cartmel B; Loftfield E; Sanft T; Chagpar AB; Zhou Y; Playdon M; Li F; Irwin ML
    J Clin Oncol; 2016 Mar; 34(7):669-76. PubMed ID: 26598750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.